Zachary Stieber, a reporter with the Epoch Times, released the CDC report on the frequency of myocarditis following the COVID vaccines.
Zachary posted the FOIAed documents here.
Every single page was redacted!
EVERY SINGLE WORD!
Zachary Stieber, a reporter with the Epoch Times, released the CDC report on the frequency of myocarditis following the COVID vaccines.
Zachary posted the FOIAed documents here.
Every single page was redacted!
EVERY SINGLE WORD!
On Feb. 29, 2024, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) presented a preliminary analysis that showed that 23 adults over the age of 65 who received a respiratory syncytial virus (RSV) vaccine developed Guillain-Barré syndrome (GBS).
When a person develops GBS, including after an infection or vaccination, the body attacks the peripheral nerves. GBS symptoms begin with muscle weakness and numbness or tingling in different parts of the body and recovery can be complete or paralysis of one or more limbs can occur, including full body paralysis, which can lead to death.
The CDC’s analysis evaluated preliminary rates of GBS following one dose of either GSK plc’s RSVPreF3+AS01 (AREXVY) vaccine or Pfizer, Inc.’s RSVPreF (ABRYSVO) vaccine and compared it to the rates of GBS in an historical control group.
The data used in the study was collected from the Centers for Medicare & Medicaid Services (CMS) administrative claims and enrollment information that was derived from CMS Medicare Shared Systems Data (SSD). The population studied included CMS Medicare Beneficiaries over age 65 years and older enrolled in Medicare Fee-for-Service.
The study period for the ABRYSVO RSV vaccine was from May 31, 2023 to Dec. 2, 2023 and for AREXVY from May 3, 2023 to Dec. 2, 2023.
The people who were used as part of the analysis either had one dose of ABRYSVO or AREXVY after the CDC’s RSV vaccine authorization and prior to the data through Dec. 2, 2023.
Nine new members named to the committee that advises the Centers for Disease Control and Prevention (CDC) on vaccine recommendations have financial ties to pharmaceutical companies or have worked with public health agencies to promote the COVID-19, RSV or HPV vaccines.
The U.S. Department of Health and Human Services (HHS) in mid-February appointed the new members to the Advisory Committee on Immunization Practices (ACIP), which shapes U.S. vaccine policy.
Commenting on the new appointments, Children’s Health Defense (CHD) President Mary Holland said:
“ACIP has long been a rubber stamp for any and all vaccines Big Pharma wants to push. But the brazenness of the HHS-Big Pharma fusion has never been so much on display.
“The only silver lining in this grotesque display is that more and more people are waking up to the reality that ACIP has nothing to do with health and everything to do with profit.”
The ACIP is described as an independent, nonfederal expert body made up of professionals with clinical, scientific and public health expertise. The committee decides which vaccines should be recommended to the public, who should take them and how often — recommendations the CDC typically rubber stamps.
This external advisory committee includes a chair, an executive secretary, and 15 voting members — 14 medical experts and a lay member representing consumers.
It also includes a non-voting body that offers input composed of eight ex officio members from other federal health departments and liaison representatives from health-related professional organizations like the American Association of Pediatrics.
However, when the committee convened last week to make its spring recommendations, it was missing so many voting members that it lacked a quorum. Vacant committee spaces on the “independent” committee had to be temporarily filled by government employees — ex officio members can be sworn in as temporary voting members.
Over the last year, HHS struggled to fill eight vacancies. An additional four members will be needed when existing members’ four-year terms are up at the end of June.
As seats on the committee sat unfilled, industry news sites like StatNews suggested the committee “appears to be atrophying” and Medriva said there is an “unprecedented lack of expertise in the committee.”
When HHS finally announced the new members to fill the vacancies, it was also reported the new members would be filling spots at last week’s meeting. However, they had not yet taken their positions at the time the meeting occurred on Feb. 28-29.
A CDC spokesperson confirmed to The Defender that nine members have been appointed to the committee, including Dr. Helen Keipp Talbot, an infectious diseases researcher at Vanderbilt University who previously served on the committee from 2018 through 2022 and will rejoin the committee to serve as chair.
Members typically are not eligible for reappointment, but in Talbot’s case, the HHS provided a waiver to that existing policy.
It’s been less than a year since the Centers for Disease Control and Prevention (CDC) recommended two new respiratory syncytial virus (RSV) vaccines — yet CDC data and the Vaccine Adverse Event Reporting System (VAERS) already show reports of 34 deaths, 302 serious adverse events and according to news reports this week, a safety signal for Guillain-Barré syndrome (GBS).
Reported cases include several instances of severe adverse events in newborns, including the death of a 27-day-old baby who was wrongly administered the vaccine, and in pregnant women and people in age groups for which the RSV vaccines were not approved.
The U.S. Food and Drug Administration (FDA) approved Pfizer’s Abrysvo and GSK’s Arexvy RSV vaccines for adults ages 60 and older — but not for children or babies.
Abrysvo is also approved for pregnant women, targeting RSV prevention in babies. The FDA approved Abrysvo and Arexvy in May 2023.
According to CDC data, approximately 9.65 million RSV vaccine doses — 6.58 million Arexvy doses and 3.06 million Abrysvo doses — were administered as of Feb. 16.
Members of the CDC’s Advisory Committee on Immunization Practices (ACIP) presented the data on deaths and adverse events related to the RSV vaccines at a Feb. 29 meeting.
Yet, ACIP — and news media reports — primarily focused on GBS safety signals, glossing over deaths and the administration of the vaccines to unauthorized age groups.
Instead, CDC officials claimed it’s too early to determine if the RSV vaccines caused the adverse events and reiterated that the shots are safe, according to The Associated Press (AP).
Experts who spoke with The Defender disputed the CDC’s reassurances. Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD), said “34 deaths in 10 months should be sufficient to pull the RSV vaccines from the market. But the FDA will not do that — nor will there be full investigations regarding these deaths.”
“I am greatly concerned with the excessive application of the RSV vaccine,” said cardiologist Dr. Peter McCullough. “We are beginning to see the tip of the iceberg in terms of serious side effects.”
Some people call it the plandemic. Others call it the scamdemic. Either way, most of the deaths did not come from the “novel” virus, but rather the toxic mRNA spike prions that invaded the vascular system of several billion people across the globe.
Another quiet Holocaust that nobody seemed to recognize, well, except for the natural health enthusiasts, who know better than to trust anything pushed by Big Pharma, especially when it’s created in a criminal-run laboratory, then injected into the sheeple’s “muscle tissue” to “build immunity.”
Then came the wave of “misinformation,” which really meant that all the truth-tellers and the whistleblowers who let everyone else know what the so-called “vaccines” really do, were labeled conspiracy theorists, anti-vaxxers and misinformation terrorists.
Meanwhile, Big Pharma, Big Media and Social Media swung the wrecking balls, destroying popular opinion and spreading ALL the misinformation about how hundreds of millions of people, who all happened to get the Covid jabs, “died suddenly” (from vascular clots, heart attacks, strokes and turbo cancer).
When the CDC created V-Safe as a way to track individuals who received the experimental COVID-19 “vaccines,” the agency vowed to be completely transparent. Remember—despite forcing millions of frightened human beings to take the jab—there were subpar clinical trials. One recipient shared, “The only reason I took this b******* vaccination is because my job gave me two choices. Sign a waiver or get the shot. I [got] the shot in fear of losing any benefits.” So it makes sense, and seems mandatory, that the CDC create a system for individuals to share how they feel after receiving the experimental, mRNA-driven “vaccines.” To build trust in that system, the CDC touted V-Safe as “the most intensive safety monitoring effort in U.S. history.” Yet, as severe adverse events, including death, rapidly ascended following the EUA-pushed jabs, the CDC failed to be transparent with the data, releasing, when ordered by the Court in 2022, only superficial details. But persistence paid off. Last month, a federal judge ordered the CDC to release all 7.8 million detailed “free-text” data entries over the next 12 months. The “free-text” section is the only place in V-Safe for participants to potentially report serious adverse events. Yesterday, the CDC released the initial batch of data containing symptoms reported after being injected. The eye-opening entries are telling.
The free-text entries are critical because, shockingly, despite having an index of “adverse events of special interest” listed in its protocol, V-Safe entirely omitted those same adverse events from being tracked. As explained by ICAN, instead of asking V-safe participants about whether, for example, they experienced things such as anaphylaxis, myocarditis, or coagulopathy after taking an entirely experimental “vaccine” based on technology never before used, the CDC carelessly only asked about minor and generalized reactions, such as “chills,” “headache,” “fatigue or tiredness,” and “vomiting.” Thus, for users who may have wanted to report more serious adverse events, they must use the “free-text” field, which allows up to 250 characters. This data is crucial to understanding the safety profile of the COVID-19 “vaccines.” The fact the CDC had not thus far voluntarily released this critical data is indicative of the overall failure of the federal government’s responsibility to protect the health of Americans.
ICAN’s initial win in two previous lawsuits opened the door to obtaining V-Safe data. However, the taxpayer-funded CDC argued that producing the “free-text” entries was too burdensome an endeavor for them to be responsible for. Nevertheless, the Court strongly disagreed, noting that the “Production of the free-text data will permit independent researchers to put the government agencies to their proof by considering all of the available data.” Reporting on this outstanding victory brought by the lawyers that regularly represent ICAN on behalf of the Freedom Coalition of Doctors for Choice, ICAN explained the Court recognized that:
“The development and distribution of the COVID-19 vaccine was one of the greatest endeavors in recent history. Predictably, the American public now seeks access to COVID-related papers to ensure that relevant government policies were — and still are — supported and justified by the available data. That is precisely what FOIA contemplates and facilitates.”
Indeed, District Court Judge Matthew Kacsmaryk’s ruling is a huge win for transparency, and yesterday’s first production of at 390,000 entries outlining what users experienced in the first two days of receiving the “vaccine” is telling. And unfortunately, it’s indicative of what’s to follow. Indeed, the “free-text” data, which is available here, has an overall theme of uneasiness. Users reported “anaphylaxis”—a severe, potentially life-threatening allergic reaction—numerous times, detailing experiences such as, “Emergency room visit for anaphylaxis … went to the ER … I had repeat facial swelling.” One user wrote, “Anaphylaxis within 10 min. of being vaccinated. Throat swollen almost shut.” Another user wrote:
“After receiving the shot (within 15 mins) I had an allergic reaction (tightening of the throat, dizziness, confusion, elevated heart rate) and was taken to the ER. Received steroid shot, Benadryl shot, and ephephrine shot. Was released to go home.” The user later wrote, “Feeling of mild allergic reaction in the throat. Elevated heart rate.”
Interestingly, thousands of users reported an odd “metallic taste” in their mouth, often accompanied by a tingling feeling in their tongue, lasting anywhere from a few minutes to hours or longer. Equally as many people—in the thousands—experienced rapid and concerning heart rates. Likewise, in addition to ongoing feelings of intense anxiety, numbness, dizziness, stiffness, fatigue, and diarrhea, thousands went to the emergency room within 24 to 48 hours of receiving the “vaccine.” One user described their experience at the ER, stating, “3 to 5 days after my shot, I experienced a rash around my eye that was painful and burning. I reported to the emergency room on Thursday, 12/24, diagnosed with shingles/herpes zoster, which I’ve never had before, so I’m just suspicious if that could have been a result of my first dose of the COVID vaccine.” Sadly, over 600 users specifically noted they were pregnant when they received the shot. Did the CDC monitor them more closely? They should have. Twenty-two users reported having a miscarriage that coincided with receiving the “vaccine.” One such user wrote:
“I had a miscarriage. I should’ve been 8 weeks pregnant but the baby stopped growing at 6 weeks which would’ve been very close to when I received my vaccine.”
It will take weeks to sift through the disturbing “free-text” entries detailing the myriad of troubling symptoms users experienced within the first couple of days after getting the “vaccine.” The 390,000 initial entries emphasize the potential for more serious adverse event symptoms like myocarditis that may be revealed as more “free-text” data files are released. Despite the unsettling entries, given the disaster that has been the COVID-19 “vaccine” campaign, reviewing the data is a massive step in the right direction. ICAN remarked, “This ruling sends a clear message to our federal agencies: we are not moving on and forgetting about the pandemic or the actions they took. ICAN will not stop until ALL the data is released to the public and there is true transparency and accountability around COVID-19.”
According to an investigation by independent journalist Paul D. Thacker published this week in the Disinformation Chronicle,, officials at the Centers for Disease Control and Prevention openly questioned the findings of its own scientists’ studies contradicting the agency’s public messaging about mask effectiveness.
The Centers for Disease Control and Prevention’s (CDC) own scientists conducted studies showing N95 respirators are no more effective at stopping viruses than surgical masks — yet the agency issued guidance contradicting those and other studies showing both types of masks are ineffective at stopping the spread of COVID-19, according to an investigation by independent journalist Paul D. Thacker.
The investigation, published this week in two parts on The Disinformation Chronicle, details how CDC leadership openly questioned the findings of CDC scientists’ studies contradicting the agency’s public messaging about mask effectiveness.
During the pandemic, mask advocates “shifted goalposts and demanded N95 respirators,” Thacker said, claiming they perform better than surgical masks at stopping the virus.
However, Thacker said CDC scientists found no difference between N95 and surgical masks in the ability to stop the spread of respiratory viruses. The findings of the CDC studies are consistent with other peer-reviewed studies on the efficacy of masks in preventing COVID-19, according to Thacker.
“But the CDC responded by saying people can’t say that,” Thacker told The Defender.
To shut down the controversy, the CDC, in its Jan. 23 post on preventing the transmission of pathogens in healthcare settings, warned researchers that to suggest facemasks and respirators are the same “is not scientifically correct,” Thacker wrote.
Childhood vaccines stand as a unique consumer product, enjoying unparalleled liability protection from the government. Given the corruption of the healthcare apparatus, it is no wonder that the U.S. Centers for Disease Control and Prevention (CDC) keeps expanding the list of recommended childhood vaccines, as happened in early 2024, says attorney Aaron Siri.
In his interview with The New American, Siri explains how the number of vaccine doses recommended for children under one year, including in-utero, surged from three to ninety over thirty-seven years, now including three doses of Covid-19 genetic therapy. This increase stems directly from the National Childhood Vaccine Injury Act of 1986, which granted legal immunity to vaccine manufacturers for injuries and deaths caused by CDC-recommended childhood vaccines.
Despite the CDC’s claims of rigorous safety trials, the truth is starkly different, according to the openly available information provided by the vaccine makers to the U.S. Food and Drug Administration (FDA). Shockingly, most safety trials last for only several days, in contrast to the several years spent on drugs that are liable to lawsuits. Furthermore, trials for childhood vaccines are conducted against other vaccines, not placebos, raising questions about the reliability of the results. Thus, a complete safety profile for these products is unknown, as highlighted by the attorney.
The nation’s top public health agency did not send an alert on COVID-19 vaccines and heart inflammation because officials were concerned they would cause panic, according to an email obtained by The Epoch Times.
The U.S. Centers for Disease Control and Prevention (CDC) in 2021 drafted an alert for heart inflammation, or myocarditis, and the Pfizer-BioNTech and Moderna COVID-19 vaccines. Officials prepared to release it to the public, taking steps including having the agency’s director review the language, internal documents show.
The alert would have been sent through the CDC’s Health Alert System (HAN) network, which goes to state and local officials, as well as doctors, across the country.
The alert was never sent.
In the May 25, 2021, email, exclusively obtained by The Epoch Times, a CDC official revealed why some officials were against sending the alert.
“The pros and cons of an official HAN are what the main discussion are right now,” Dr. Sara Oliver, the official, wrote in the missive. “I think it’s likely to be a HAN since that is CDC’s primary method of communications to clinicians and public health departments, but people don’t want to appear alarmist either.”
Nearly 130 pregnant women and 25 children under age 2 were given the wrong respiratory syncytial virus (RSV) vaccine, according to the Centers for Disease Control and Prevention (CDC).
The children were mistakenly administered either Pfizer’s Abrysvo or GSK’s (formerly GlaxoSmithKline) Arexvy RSV vaccines. Both are approved by the U.S. Food and Drug Administration (FDA) for adults ages 60 and older — but not for children or babies.
For babies, the CDC recommends a monoclonal antibody — nirsevimab (Beyfortus) — produced by AstraZeneca and Sanofi. The CDC also recommends Beyfortus for children ages 8-19 months who are at increased risk of severe RSV.
Although Arexvy and Abrysvo are approved for older adults, only Abrysvo is approved for pregnant women to prevent RSV in their babies. All of the 128 pregnant women who received the wrong vaccine were administered Arexvy.
RSV is a common respiratory virus that usually causes mild, cold-like symptoms.
You must be logged in to post a comment.